Wei Lin
Chief Tech/Sci/R&D Officer chez REVOLUTION MEDICINES, INC.
Fortune : 3 M $ au 31/03/2024
Postes actifs de Wei Lin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| 2SEVENTY BIO, INC. | Director/Board Member | 07/03/2023 | - |
| Independent Dir/Board Member | 07/03/2023 | - | |
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 01/04/2023 | - |
Historique de carrière de Wei Lin
Anciens postes connus de Wei Lin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ERASCA, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 | 10/04/2023 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 14/11/2018 | 05/01/2021 |
| Roche (China) Co. Ltd. | Corporate Officer/Principal | 01/01/2006 | 01/01/2009 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Formation de Wei Lin
| Haverford College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| Chine | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Roche (China) Co. Ltd. |
